POLYPEPTIDE OF SOLUBLE RECEPTOR 3 FIBROBAL GROWTH FACTOR (FGR3) FOR APPLICATION FOR THE PURPOSE OF PREVENTION OR TREATMENT OF DISTURBANCES ASSOCIATED WITH DECOMPOSITION OF SKELETON GROWTH

摘要

The present invention relates to the prevention or treatment of disorders associated with a slowdown in skeletal growth, in particular skeletal diseases, developing in patients with abnormally increased activation of fibroblast growth factor receptor 3 (FGFR3), in particular, with the expression of a constitutively activated mutant FGFR3. More specifically, the present invention relates to soluble FGFR3 for use in the prevention or treatment of achondroplasia.